Ewha Med J.  2024 Jan;47(1):e10. 10.12771/emj.2024.e10.

Sex and Gender Equity in Research (SAGER): rationale for the SAGER guidelines and recommended use: a Korean translation

Affiliations
  • 1EASE Gender Policy Committee/Reproductive Health Matters, London, UK
  • 2Department of Community Medicine, University of Connecticut School of Medicine, Farmington, CT, USA
  • 3Istituto Superiore di Sanità, Rome, Italy
  • 4Cochrane Editorial Unit, London, UK
  • 5Journal of the International AIDS Society, Geneva, Switzerland


Figure

  • 그림 1. 투고 원고에 대한 편집자의 초기 심사를 안내하는 SAGER(Sex and Gender Equity in Research) 흐름도.


Cited by  1 articles

Gender equity in medical journals in Korea and this issue
Sun Huh
Ewha Med J. 2024;47(1):e1.    doi: 10.12771/emj.2024.e1.


Reference

References

1. Coen S, Banister E. What a difference sex and gender make: a gender, sex and health research casebook. Ottowa: Canadian Institutes of Health Research;2012.
2. Hoffman DE, Tarzian AJ. The girl who cried pain: a bias against women in the treatment of pain. J Law Med Ethics. 2001; 29(1):13–27. DOI: 10.1111/j.1748-720X.2001.tb00037.x. PMID: 11521267.
3. Institute of Medicine [IOM]. Sex-specific reporting of scientific research: a workshop summary. Washington: The National Academies Press;2012.
4. Geller SE, Koch A, Pellettieri B, Carnes M. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress? J Womens Health. 2011; 20(3):315–320. DOI: 10.1089/jwh.2010.2469. PMID: 21351877. PMCID: PMC3058895.
5. Leopold SS, Beadling L, Dobbs MB, Gebhardt MC, Lotke PA, Manner PA, et al. Fairness to all: gender and sex in scientific reporting. Clin Orthop Relat Res. 2014; 472:391–392. DOI: 10.1007/s11999-013-3397-5. PMID: 24276859. PMCID: PMC3890179.
6. Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014; 509(7500):282–283. DOI: 10.1038/509282a. PMID: 24834516. PMCID: PMC5101948.
Article
7. Kim ESH, Menon V. Status of women in cardiovascular clinical trials. Arterioscler Thromb Vasc Biol. 2009; 29:279–283. DOI: 10.1161/ATVBAHA.108.179796. PMID: 19221204.
Article
8. Johnson JL, Greaves L, Repta R. Better science with sex and gender: facilitating the use of a sex and gender-based analysis in health research. Int J Equity Health. 2009; 8:14. DOI: 10.1186/1475-9276-8-14. PMID: 19419579. PMCID: PMC2689237.
Article
9. Greenspan JD, Craft RM, LeResche L, Arendt-Nielsen L, Berkley KJ, Fillingim RB, et al. Studying sex and gender differences in pain and analgesia: a consensus report. Pain. 2007; 132:S26–S45. DOI: 10.1016/j.pain.2007.10.014. PMID: 17964077. PMCID: PMC2823483.
10. U.S. Government Accountability Office. GAO-01-286R. Drug safety: most drugs withdrawn in recent years had greater health risks for women [Internet]. Washington (DC): U.S. Government Accountability Office;c2001. [cited 2016 Jan 2]. Available from: http://www.gao.gov/products/GAO-01-286R.
11. Food and Drug Administration. Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist), FDA Drug Safety Communication [Internet]. Silver Spring (MD): Food and Drug Administration;c2013. [cited 2016 Jan 2]. Available from: https://www.fda.gov/files/drugs/published/Drug-Safety-Communication--Risk-of-next-morning-impairment-after-use-of-insomnia-drugs--FDA-requires-lower-recommended-doses-for-certain-drugs-containing-zolpidem-%28Ambien--Ambien-CR--Edluar--and-Zolpimist%29.pdf.
12. Linder A, Schick S, Hell W, Svensson M, Carlsson A, Lemmen P, et al. ADSEAT: adaptive seat to reduce neck injuries for female and male occupants. Accid Anal Prev. 2013; 60:334–343. DOI: 10.1016/j.aap.2013.02.043. PMID: 23602605.
Article
13. Jakobsson L, Norin H, Svensson MY. Parameters influencing AIS 1 neck injury outcome in frontal impacts. Traffic Inj Prev. 2004; 5:156–163. DOI: 10.1080/15389580490435989. PMID: 15203952.
14. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005; 353:2779–2787. DOI: 10.1056/NEJMsa053234. PMID: 16382064. PMCID: PMC1568386.
Article
15. Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One. 2013; 8(12):e83138. DOI: 10.1371/journal.pone.0083138. PMID: 24386151. PMCID: PMC3873291.
16. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010; 152(11):726–732. DOI: 10.7326/0003-4819-152-11-201006010-00232. PMID: 20335313.
Article
17. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust. 2006; 185(5):263–267. DOI: 10.5694/j.1326-5377.2006.tb00557.x. PMID: 16948622.
Article
18. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010; 8(6):e1000412. DOI: 10.1371/journal.pbio.1000412. PMID: 20613859. PMCID: PMC2893951.
19. International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals, updated December 2014 [Internet]. Philadelphia (PA): International Committee of Medical Journal Editors;c2014. [cited 2016 Jan 2]. Available from: https://www.icmje.org/icmje-recommendations.pdf.
20. Taking sex into account in medicine. Lancet. 2011; 378(9806):1826. DOI: 10.1016/S0140-6736(11)61795-9. PMID: 22118430.
21. Doull M, Runnels VE, Tudiver S, Boscoe M. Appraising the evidence: applying sex- and gender-based analysis (SGBA) to Cochrane systematic reviews on cardiovascular diseases. J Womens Health. 2010; 19:997–1003. DOI: 10.1089/jwh.2009.1626. PMID: 20384450.
Article
22. Doull M, Welch V, Puil L, Runnels V, Coen SE, Shea B, et al. Development and evaluation of lying sex- and gender-based analyedge translation tool to aid the implementation of sex/gender analysis in systematic reviews: a pilot study. PLoS One. 2014; 9(11):e110786. DOI: 10.1371/journal.pone.0110786. PMID: 25372876. PMCID: PMC4220945.
23. Nowatzki N, Grant KR. Sex is not enough: the need for gender-based analysis in health research. Health Care Women Int. 2011; 32(4):263–277. DOI: 10.1080/07399332.2010.519838. PMID: 21409661.
24. Canadian Institutes of Health Research. Gender, sex and health research guide: a tool for CIHR applicants [Internet]. Ottawa (ON): Canadian Institutes of Health Research;c2014. [cited 2016 Jan 2]. Available from: http://www.cihr-irsc.gc.ca/e/32019.html.
25. National Institutes of Health [NIH]. NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical researchs implem [Internet]. Bethesda (MD): NIH;c2001. [cited 2016 Jan 2]. Available from: http://grants.nih.gov/grants/funding/women_min/women_min.htm.
26. Nieuwenhoven L, Klinge I. Scientific excellence in applying sex- and gender-sensitive methods in biomedical and health research. J Womens Health. 2010; 19(2):313–321. DOI: 10.1089/jwh.2008.1156. PMID: 20136550.
Article
27. Nature19 sexism. Nature. 2012; 491(7425):495. DOI: 10.1038/491495a.
28. Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. Sex and gender analysis checklists [Internet]. Brussels (BE): European Commission;c2014. [cited 2016 Jan 2]. Available from: http://genderedinnovations.stanford.edu/researchers.html.
Full Text Links
  • EMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr